Cancer of Unknown Origin
3 clinical trials · Condition
◉ Watch Cancer of Unknown Origin
| Record | Firm | Date |
|---|---|---|
| A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin. (NCT03628079) | Repos Pharma | 2018-05-25 |
| Genomic Testing and Resulting Medical Decisions (NCT03301493) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2017-03-30 |
| Engagement of Patients With Advanced Cancer (NCT02966509) | Stanford University | 2013-08-01 |
Track Cancer of Unknown Origin automatically
Every clearance here is in the API, with alerts when new ones post.